Lead the second-ranking self-care business in the Middle East, overseeing renowned global brands including Claritine, Bepanthen, Aspirin, Redoxon, Priorin, Canesten, and Rennie. Attained the top position in Allergy, Skin Care, and Immunity segments, and secured the second position in Antifungal and Hair Regrowth categories according to IQVIA 2023, achieving a share growth of over 90bps.Developed the strategic Fit-2-Win plan aimed at achieving a +13% CAGR growth by 2027 focusing on promising market categories, innovative modern marketing tactics, localization strategies, and customer excellence programs.Committed to fostering talent development through proactive mentorship, training initiatives, and continuous learning opportunities.

As the Founder and CEO of an early-stage software startup currently in incubation, I am focused on transforming the automotive industry by digitizing and streamlining workshop operations, service workflows, and customer experiences. Our platform is designed to empower auto mechanics, workshops, and agencies with tools to optimize efficiency and elevate service standards. Leading a passionate team, I’m committed to leveraging technology to set a new benchmark for operational excellence in the automotive sector, with a vision to redefine the future of automotive services. Launching soon!

Initiated a transformational journey to reposition the Professional & OTC organization, elevating its status from a discretionary addition to a pivotal driver of strategic growth. Implemented a "professional first" go-to-market business model, facilitating precise targeting, communication strategies, and engagement metrics. Achieved a remarkable CAGR growth of 15% in Self Care, alongside a notable increase in EBIT by +20% CAGR and a market share expansion of +245bps Directed a cross-functional agile team comprising Commercial, Marketing, Finance, Supply Chain, Digital, and Regulatory departments, orchestrating agile decision-making processes and fostering operational excellence throughout strategic business endeavors.Pioneered digital campaigns for Regaine and Imodium tailored for Middle East markets, emphasizing comprehensive funnel planning in collaboration with creative and media agencies. The Regaine campaign surpassed KPIs and market benchmarks, resulting in accelerated growth within the Hair Regrowth category during 2021-22Performed thorough analysis of category dynamics, consumer behavior, healthcare professionals' preferences, and digital trends to refine marketing strategies and maximize promotional budget allocation. Collaborated extensively with Sqreem, IQVIA, Veeva, and Salesforce.com to leverage HCP insights, conduct Route-to-Purchase modeling, and assess Market Opportunity Sizing using IQVIA and IPSOS data.

A part of Emerging Market Leadership Team, managing business with territorial scope including Middle East, Africa, Turkey, & CIS regions.Key priorities to drive growth by exploring new markets (geographical/ segment) and enhance marketing, medical, and clinical, capabilities to enable effective execution by driving clinical marketing - PCSA, Van Gogh, reimbursement / pricing governance & partnership opportunities with insulin & BGM manufacturers.Leading Annual Strategic Review (ASR) planning for region. Providing guidance and support to Country Business Leaders in outlining their 3 years vision and direction i.e. category share, expansion, product rationalization, GTM, clinical & marketing support and roadmap, resource planning, and alignment with global expectations.

Spearheaded the Middle East cluster, achieving a robust CAGR revenue growth of +19% and GP +21% through targeted geographical expansion and innovative market segment development. Notably, instrumental investment initiatives in Saudi Arabia during FY110-11 catalyzed business doubling within three years.Surpassed the 50% category share mark across all strategic market segments within a three-year timeframe for Syringe & PN, elevating the Micro-Fine brand to leadership status. Expanded the business development presence in Maghreb markets through strategic initiatives including new distributor onboarding, comprehensive training programs, and realignment of the sales force model, resulting in consistent annual growth of 15%.Acknowledge with the prestigious “Outstanding Performance Award” for achieving the largest category share gain in Saudi/UAE market, reflecting exceptional leadership and market penetration achievements

Revamped guidelines for Distributor Management, emphasizing the organization's expectations from distributor partners, including alignment on forecast, inventory management, and operational KPIs such as sales, % SGA, pricing, and channel contribution.Initiated a World Diabetes Day Corporate Social Responsibility (CSR) campaign across Pakistan in partnership with Novo Nordisk, Eli Lilly, Sanofi, and J&J. This groundbreaking initiative marked the first-ever consumer-targeted awareness campaign, incorporating both above-the-line (ATL) and below-the-line (BTL) activities.

As a member of the Management Operating Committee (MOC), led the Medical & Dental Division for Pakistan and Afghanistan transforming it into the most profitable unit and contributing to 33% of the company’s EBITEstablished a robust organizational structure integrating marketing, sales, and clinical functions, alongside implementing a new go-to-market business model involving 14 distributors, 4 commission agents, and 10 distributor sales teams.Recognized for leadership excellence with the prestigious "Best Leader 2007" award conferred by the 3M regional office.

Directed the strategic alignment of marketing efforts and communication strategies on company, therapy lines, and services and launched innovative analog Pen Devices (NovoRapid, NovoMix).Built and cultivated the sales team, overseeing the hiring and training of a new cadre of 20 diabetes specialists throughout Pakistan.Offered influential leadership in steering the Pakistan Endocrinology & Gastroenterology Society (PEGS) towards endorsing the inaugural growth hormone treatment guidelines.

With a background spanning 3 years in the social development sector under USAID support, I played a pivotal role in conceptualizing and executing a novel hormonal product range for GSM, enhancing women's options in line with their needs.Contributed to crafting proposals for funding from USAID, Packard, and the Bill Gates Foundation, resulting in the successful acquisition of $23M from USAID for a 4-year project and $3M from the Packard Foundation for a 2-year initiative, advancing the project's scope beyond 2005.

Key player in enhancing divisional standing by contributing 20% of total company revenue through marketing, sales, and clinical excellence. Responsible for identifying market opportunities and prioritizing product launches including Pegasys, Cellcept, and Zenapax.